Dominic Piscitelli

This profile gathers the share dealings of Dominic Piscitelli across 2 companies, led by Oric Pharmaceuticals, Inc. and Anaptysbio, Inc. In total, 30 filings cover trades dated from 3 December 2018 to 20 October 2026.

In open-market terms, that means 1 purchase worth €290k on one side and 17 sales worth €3.8M on the other. Sales outweigh purchases by €3.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 12 option exercises. So far in 2026, the count stands at no purchases and 5 sales.

Most recently, on 21 October 2026, the filings show an option exercise worth €54k in Oric Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,667 days ago, on 31 March 2022. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.